Cargando…
Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance
Diabetes, which is mainly characterized by increased apoptosis and dysfunction of beta (β) cells, is a metabolic disease caused by impairment of pancreatic islet function. Previous studies have demonstrated that death-associated protein kinase-related apoptosis-inducing kinase-2 (Drak2) is involved...
Autores principales: | Han, Ming, Lu, Yuting, Tao, Yunhua, Zhang, Xinwen, Dai, Chengqiu, Zhang, Bingqian, Xu, Honghong, Li, Jingya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385282/ https://www.ncbi.nlm.nih.gov/pubmed/37513887 http://dx.doi.org/10.3390/ph16070975 |
Ejemplares similares
-
Luteolin decreases the UVA-induced autophagy of human skin fibroblasts by scavenging ROS
por: Yan, Miaomiao, et al.
Publicado: (2016) -
Luteolin Treatment Protects against Renal Ischemia-Reperfusion Injury in Rats
por: Hong, Xin, et al.
Publicado: (2017) -
Role of Luteolin-Induced Apoptosis and Autophagy in Human Glioblastoma Cell Lines
por: Lee, Hye-Sung, et al.
Publicado: (2021) -
Luteolin prevents uric acid-induced pancreatic β-cell dysfunction
por: Ding, Ying, et al.
Publicado: (2014) -
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment
por: Wang, Yu, et al.
Publicado: (2021)